UroSolutions
Company: UroSolutions, Inc.
Company Description: UroSolutions, Inc, has only six employees, but its innovative health care product, the UroCycler, has won 14 region, state, and national awards. Dr. David Flinchbaugh, founder and inventor, set up manufacturing in 2002 to produce 1,000 units/day. Seven patents describe this totally unique bladder management system, a urological breakthrough benefitting indwelling catheter users.
Nomination Category: Company, Office & Product Awards Categories
Nomination Sub Category: Best New Product or Service
Nomination Title: The UroCycler by UroSolutions, Inc.
1. Tell the story of this nominated product or service (up to 500 words): its function, its features and benefits, and how it differs from competitive offerings. Include in your description the date in 2004 on which this product or service was introduced to the U.S. marketplace:
UroSolutionsTM, Inc. has only six employees, but its innovative product, the
UroCycler , has won fourteen region, state, national, and international awards.
After incorporating in 2001 its principal founder and product inventor, Dr.
David E. Flinchbaugh, organized a medical device manufacturing team and
facilities to perfect this unique new product for the world marketplace for January 5, 2004 distribution. He has been granted a total of seven patents and two trademarks
describing this device.The UroCycler is a totally unique bladder management system which has proven to be of great benefit to indwelling catheter users. It is hailed by experts in the
field as "the most significant breakthrough in urology care in 70 years, since the
introduction of the Foley catheter" Health care professionals and patients in
all 50 states and over 30 countries are discovering great value, comfort, and
cost savings with this life-enhancing device. The heart of the system is a precision, passive, low-pressure magnetic valve which restores nearly normal patient bladder
function. Patients report the beneficial experience of reduced urinary tract infections due to "washout", elimination of bladder spasms, elimination of encrustation, and fewer continence problems. This device has earned an FDA 510(k) certification as an anti-reflux valve, FDA GMP quality control standards, Underwriters Labs. approval for the CE Mark, and ISO standards certification. More extensive clinical studies are in progress.The Associatjon for the Advancement of Medical Instrumentation awarded the
UroCycler and its inventor its highest honor, the Laufman-Greatbach Prize and a
Foundation Grant. The National Multiple Sclerosis Society jointly with the
Engineering Society of Detroit presented their daVinci Award for Assistive
Technology to enhance the quality of life. The Society of Manufacturing Engineers presented their Albert M Sargent Internationa1 Progress Award for significant accomplishments increasing productivity by innovative manufacturing processes, materials, and systems. The UroCycler became the Grand Prize Winner for Excellence in Design, which included a $6,000 Technology Award. Canon Communications presented their coveted Gold Winner Medical Design Excellence Award. R&D Magazine se1ected this new product for an R & D 100 Award. Additional honors include the Governor Jeb Bush New Product Award, the Governor A. W. Gilcrest Humanitarian Award, and the National Society of
Professional Engineer's New Product award for 2004.From hospital use and manufacturers statistics, it is estimated that over 30
million indwelling catheters are used in the USA each year and about 125-million
worldwide. About 40% of the nosocomial infections that threaten lives in American
hospitals each year are classified as urinary tract infections. This bladder
management system is finding acceptance in brain and spinal-cord injury units,
nursing homes, rehabilitation centers, long term care facilities, clinics and
medical education centers, and hospitals where surgeries are performed and serious injuries are treated. Catheters are frequently used with patients undergoing hip replacement and knee replacement surgery. It is our belief that when statistically significant clinical studies are performed using the UroCycler, this device may become a "standard of care" which is mandated for patient safety and reduced risk factor .
2. List hyperlinks to any online news stories, press releases, or other documents that support the claims made in the section above. You may include links to product photos, service logos, etc. IMPORTANT: List each link on a separate line, begin each link with http://, and enclose each link in square brackets; for example, [http://www.website.com]:
http://www.urosolutions.com
http://www.btjonline.com/stories/0301company.shtml
http://www.devicelink.com/expo/awards02/03rehab.html
http://www.extendedcarenews.com/ecpn/orrc.cfm
http://www.uiausa.com/inventororg.htm
http://www.ieeeusa.org/business/localnetwork.asp
http://www.annals.org/cgi/content/full/137/2/125]
http://www.urosolutions.com/html/about_us.html
3. Provide a brief (up to 100 words) biography about the leader(s) of the team that development this nominated product or service:
David E. Flinchbaugh, Ph.D., CEO of UroSolutions, Inc., is a vibrant, age 70,
Physicist from Poughkeepsie, NY. His Union, College and U. Conn, degrees precede diplomas from Case Institute, Harvard, and Florida Tech. Having taught new courses at ten colleges, he serves as a Director for six corporations. He
authored 125 published papers in physics, lasers, sensors, medical and health
care devices and won numerous honors. A registered FL and PA Professional
Engineer, he has created 196 inventions to date. Several patents benefited IBM,
United Technologies, and Westinghouse. His latest patents benefit a Foundation dedicated to Humanitarian interests.